Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer.
Bartolacci C, Andreani C, Curcio C, Occhipinti S, Massaccesi L, Giovarelli M, Galeazzi R, Iezzi M, Tilio M, Gambini V, Wang J, Marchini C, Amici A.
Bartolacci C, et al. Among authors: amici a.
Cancer Immunol Res. 2018 Dec;6(12):1486-1498. doi: 10.1158/2326-6066.CIR-18-0179. Epub 2018 Oct 16.
Cancer Immunol Res. 2018.
PMID: 30327365